83 related articles for article (PubMed ID: 17548050)
1. Tyk2 mediates effects of urokinase on human vascular smooth muscle cell growth.
Patecki M; von Schaewen M; Tkachuk S; Jerke U; Dietz R; Dumler I; Kusch A
Biochem Biophys Res Commun; 2007 Aug; 359(3):679-84. PubMed ID: 17548050
[TBL] [Abstract][Full Text] [Related]
2. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.
Kiyan J; Haller H; Dumler I
Exp Cell Res; 2009 Apr; 315(6):1029-39. PubMed ID: 19133257
[TBL] [Abstract][Full Text] [Related]
3. Monocyte-expressed urokinase regulates human vascular smooth muscle cell migration in a coculture model.
Kusch A; Tkachuk S; Lutter S; Haller H; Dietz R; Lipp M; Dumler I
Biol Chem; 2002 Jan; 383(1):217-21. PubMed ID: 11928816
[TBL] [Abstract][Full Text] [Related]
4. Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-Tyk2 interaction.
Kusch A; Tkachuk S; Haller H; Dietz R; Gulba DC; Lipp M; Dumler I
J Biol Chem; 2000 Dec; 275(50):39466-73. PubMed ID: 10995743
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-induced migration of human vascular smooth muscle cells requires coupling of the small GTPases RhoA and Rac1 to the Tyk2/PI3-K signalling pathway.
Kiian I; Tkachuk N; Haller H; Dumler I
Thromb Haemost; 2003 May; 89(5):904-14. PubMed ID: 12719789
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
Kiyan J; Smith G; Haller H; Dumler I
Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
[TBL] [Abstract][Full Text] [Related]
7. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells.
Dumler I; Weis A; Mayboroda OA; Maasch C; Jerke U; Haller H; Gulba DC
J Biol Chem; 1998 Jan; 273(1):315-21. PubMed ID: 9417082
[TBL] [Abstract][Full Text] [Related]
8. The tight junction protein ZO-2 mediates proliferation of vascular smooth muscle cells via regulation of Stat1.
Kusch A; Tkachuk S; Tkachuk N; Patecki M; Park JK; Dietz R; Haller H; Dumler I
Cardiovasc Res; 2009 Jul; 83(1):115-22. PubMed ID: 19380416
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta.
Kiyan J; Kiyan R; Haller H; Dumler I
EMBO J; 2005 May; 24(10):1787-97. PubMed ID: 15889147
[TBL] [Abstract][Full Text] [Related]
10. The tight junction protein ZO-2 and Janus kinase 1 mediate intercellular communications in vascular smooth muscle cells.
Tkachuk N; Tkachuk S; Patecki M; Kusch A; Korenbaum E; Haller H; Dumler I
Biochem Biophys Res Commun; 2011 Jul; 410(3):531-6. PubMed ID: 21679692
[TBL] [Abstract][Full Text] [Related]
11. UPA promotes lipid-loaded vascular smooth muscle cell migration through LRP-1.
Lugano R; Peña E; Casani L; Badimon L; Padró T
Cardiovasc Res; 2013 Nov; 100(2):262-71. PubMed ID: 23812296
[TBL] [Abstract][Full Text] [Related]
12. Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells.
Dumler I; Kopmann A; Weis A; Mayboroda OA; Wagner K; Gulba DC; Haller H
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):290-7. PubMed ID: 9974409
[TBL] [Abstract][Full Text] [Related]
13. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
14. Myxoma virus selectively disrupts type I interferon signaling in primary human fibroblasts by blocking the activation of the Janus kinase Tyk2.
Wang F; Barrett JW; Shao Q; Gao X; Dekaban GA; McFadden G
Virology; 2009 Apr; 387(1):136-46. PubMed ID: 19254804
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
Ueshima S; Fukao H; Okada K; Matsuo O
Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564
[TBL] [Abstract][Full Text] [Related]
16. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
17. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view.
Binder BR; Mihaly J; Prager GW
Thromb Haemost; 2007 Mar; 97(3):336-42. PubMed ID: 17334498
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling: role for the urokinase receptor.
Kiyan J; Kusch A; Tkachuk S; Krämer J; Haller H; Dietz R; Smith G; Dumler I
Atherosclerosis; 2007 Dec; 195(2):254-61. PubMed ID: 17275828
[TBL] [Abstract][Full Text] [Related]
19. Raloxifene plus 17beta-estradiol inhibits proliferation of primary cultured vascular smooth muscle cells and human mammary endothelial cells via the janus kinase/signal transducer and activator of transcription3 cascade.
Wang TH; Xiang QL; Chen JW; Pan H; Cui YH
Eur J Pharmacol; 2007 Apr; 561(1-3):7-13. PubMed ID: 17336289
[TBL] [Abstract][Full Text] [Related]
20. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]